Literature DB >> 30266659

Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis.

Wanlada Sawangarun1, Masita Mandasari1, Junko Aida2, Kei-Ichi Morita3, Kou Kayamori1, Tohru Ikeda1, Kei Sakamoto4.   

Abstract

Notch signaling functions in diverse developmental and homeostatic processes, including stem cell self-renewal and cell fate determination. Notch1-inactivating mutations are frequently detected in skin and oro-esophageal cancers, suggesting a role for Notch1 as a tumor suppressor. Here, we clarify the contribution of Notch1 deficiency to oro-esophageal tumorigenesis using a physiological experimental model. Tongue and esophageal tumors induced in mice by 4-nitroquinoline-1-oxide (4-NQO) showed pathophysiological similarities to human tumors, including decreased Notch1 expression in the basal cells. We created mutant mice (N1cKO), in which the Notch1 gene was disrupted specifically in the squamous epithelium. The epithelium formed normally in N1cKO mice, and although multiple skin tumors were detected at 65 weeks, no tumors developed in the tongue and esophagus. However, 4-NQO-induced tumorigenesis assays revealed that tumor onset occurred earlier in N1cKO mice than in wild-type littermates, and the tumors arose preferentially from the Notch1-negative epithelium, indicating the tumor susceptibility of Notch1-deficient epithelium. Notch1 regulates the expression of TERT, and age-related telomere erosion was more rapid in Notch1-deficient basal cells. Our results indicated that although Notch1 deficiency had little effect on squamous epithelium formation, it predisposed the affected epithelium to tumor development, at least in part through accelerated telomere erosion.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Esophageal cancer; Head and neck cancer; Notch1; TERT; Telomere

Mesh:

Substances:

Year:  2018        PMID: 30266659     DOI: 10.1016/j.yexcr.2018.09.019

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

Review 1.  Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy.

Authors:  Xu Zhang; Yuxiang Wang; Linghua Meng
Journal:  Acta Pharm Sin B       Date:  2021-09-30       Impact factor: 14.903

2.  Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses.

Authors:  Giulia Monticone; Zhi Huang; Fred Csibi; Silvana Leit; David Ciccone; Ameya S Champhekar; Jermaine E Austin; Deniz A Ucar; Fokhrul Hossain; Salome V Ibba; A Hamid Boulares; Nicholas Carpino; Keli Xu; Samarpan Majumder; Barbara A Osborne; Christine Loh; Lucio Miele
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 3.  Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.

Authors:  Andrew C Brane; Trygve O Tollefsbol
Journal:  Cells       Date:  2019-02-21       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.